Peripheral Administration of Carbenoxolone Reduces Ischemic Reperfusion Injury in Transient Model of Cerebral Ischemia

Journal of Stroke and Cerebrovascular Diseases

Volumn 18, Issue 2, 2009, Pages 81-85

  Vakili, Abedin ^a   Hosseinzadeh, Seyed Ahmad ^a   Khorasani, Mahdi Zahedi ^a  

^a SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carbenoxolone; rat; transient focal cerebral ischemia

Indexed keywords

CARBENOXOLONE; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN TISSUE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SCORING SYSTEM; STRIATE CORTEX; TRANSIENT ISCHEMIC ATTACK; WISTAR RAT;

ANIMALS; BRAIN INFARCTION; BRAIN ISCHEMIA; CARBENOXOLONE; CEREBRAL CORTEX; CORPUS STRIATUM; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 60749083838     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2008.09.018     Document Type: Article

References (32)

1. Turpie A.G., and Thomson T.J. Carbenoxolone sodium in the treatment of gastric ulcer with special reference to side effects. Gut 6 (1965) 591-594
2. Davidson J.S., and Baumgarte I.M. Glycyrrhetinic acid derivatives. A novel class of inhibitors of gap-junctional intercellular communication: Structure-activity relationships. J Pharmacol Exp Ther 246 (1988) 1104-1107
3. Frantseva M.V., Kokarovtseva L., Naus C.C.G., et al. Specific gap junctions enhance the neuronal vulnerability to brain traumatic injury. J Neurosci 22 (2002) 644-653
4. Frantseva M.V., Kokarovtseva L., and Perez Velazquez J.L. Ischemia induced brain damage depends on specific gap-junctional coupling. J Cereb Blood Flow Metab 22 (2002) 453-462
5. Prez Velazques J.L., Kokarovtseva L., Sarbaziha R., et al. Role of gap junctional coupling in astrocytic networks in the determination of global ischemia-induced oxidative stress and hippocampal damage. Eur J Neurosci 23 (2006) 1-10
6. Ozog M.A., Siushansian R., and Naus C.C.G. Blocked gap junctional coupling increases glutamate-induced neurotoxicity in neuron-astrocyte co-cultures. J Neuropathol Exp Neurol 61 (2002) 132-141
7. Zündorf G., Kahlert S., and Reiser G. Gap-junction blocker carbenoxolone differentially enhances NMDA-induced cell death in hippocampal neurons and astrocytes in co-culture. J Neurochem 102 (2007) 508-521
8. Blanc E.M., Bruce-Keller A.J., and Mattson M.P. Astrocytic gap junctional communication decreases neuronal vulnerability to oxidative stress-induced disruption of Ca2+ homeostasis and cell death. J Neurochem 70 (1998) 958-970
9. Vakili A., Kataoka H., and Plesnila N. Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia. J Cereb Blood Flow Metab 25 (2005) 1012-1019
10. Swanson R.A., Morton M.T., Tsao-Wu G., et al. Semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10 (1990) 290-293
11. Zhang G.Y., Cao Y.H., Xu Y., et al. Effect of gap junction in the ischemic injury of focal cerebral infarct. Chin J Clin Rehab 8 (2004) 4510-4511
12. Goldberg G.S., Moreno A.P., Bechberger J.F., et al. Evidence that disruption of connexon particle arrangements in gap junction plaques is associated with inhibition of gap junctional communication by a glycyrrhetinic acid derivative. Exp Cell Res 222 (1996) 48-53
13. Bani-Yaghoub M., Underhill T.M., and Naus C.C. Gap junction blockage interferes with neuronal and astroglial differentiation of mouse P19 embryonal carcinoma cells. Dev Genet 24 (1999) 69-81
14. Nagy J.I., and Li W.E. A brain slice model for in vitro analyses of astrocytic gap junction and connexin43 regulation: Actions of ischemia, glutamate and elevated potassium. Eur J Neurosci 12 (2000) 4567-4572
15. Contreras J.E., Sáncheza H.A., Véliza L.P., et al. Role of connexin-based gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue. Brain Res Rev 47 (2004) 290-303
16. Azzam E.I., de Toledo S.M., and Little J.B. Direct evidence for the participation of gap-junction mediated intercellular communication in the transmission of damage signals from alpha-particle irradiated to nonirradiated cells. Proc Natl Acad Sci U S A 98 (2001) 473-478
17. Cotrina M.L., Kang J., Lin J.H.C., et al. Astrocytic gap junctions remain open during ischemic conditions. J Neurosci 18 (1998) 2520-2537
18. Thompson R.J., Zhou N., and MacVicar B.A. Ischemia opens neuronal gap junction hemichannels. Science 312 (2006) 924-927
19. Haraguchi H., Ishikawa H., Mizutani K., et al. Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata. Bioorg Med Chem 6 (1998) 339-347
20. Nelson C.W., Wei E.P., Povlishock J.T., et al. Oxygen radicals in cerebral ischemia. Am J Physiol 263 (1992) 1356-1362
21. Chan P. Oxygen radicals in focal cerebral ischemia. Brain Pathol 4 (1994) 59-65
22. Hunter A.J., Mackay K.B., and Rogers D.C. To what extent have functional studies of ischemia in animals been useful in the assessment of potential neuroprotective agents?. Trends Pharmacol Sci 19 (1998) 59-66
23. Wood N.I., Sopesen B.V., Roberts J.C., et al. Motor dysfunction in a photothrombotic focal ischemia model. Behav Brain Res 78 (1996) 113-120
24. van der Staay F.J., Augstein K.H., and Horváth E. Sensorimotor impairments in Wistar Kyoto rats with cerebral infarction, induced by unilateral occlusion of the middle cerebral artery: Recovery of function. Brain Res 715 (1996) 180-188
25. Wahl F., Allix M., Plotkine M., et al. Neurological and behavioral outcomes of focal cerebral ischemia in rats. Stroke 23 (1992) 267-272
26. Belayev L., Khoutorova L., Deisher T.A., et al. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats. Stroke 34 (2003) 758-763
27. González-Falcón A., Candelario-Jalil E., García-Cabrera M., et al. Effects of pyruvate administration on infarct volume and neurological deficits following permanent focal cerebral ischemia in rats. Brain Res 990 (2003) 1-7
28. Marshall J.W., and Ridley R.M. Assessment of functional impairment following permanent middle cerebral artery occlusion in a non-human primate species. Neurodegeneration 5 (1996) 275-286
29. Brdon J., Kaiser S., Hagemann F., et al. Comparison between early and delayed systemic treatment with candesartan of rats after ischemic stroke. J Hypertens 25 (2007) 187-196
30. Yang Y., Li Q., Miyashita H., et al. Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia. J Neurosurg 92 (2000) 841-847
31. Kawamata T., Alexis N.E., Dietrich W.D., et al. Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal cerebral infarction in the rat. J Cereb Blood Flow Metab 16 (1996) 542-547
32. Yamamoto M., Tamura A., Kirino T., et al. Effects of thyrotropin-releasing hormone on behavioral disturbances in middle cerebral artery-occluded rats. Eur J Pharmacol 197 (1991) 117-123